Correspondingly, shRNA-mediated knockdown of IRF4 counteracted exhaustion, inhibited T cell differentiation, improved CAR T cell cytotoxicity, and augmented CAR T cell performance in leukemia bearing mice (45). This evidence concerns the gene IRF4 and leukemia.